Debborah Maguire

Title: Debborah Maguire: Innovator in Biotechnology

Introduction

Debborah Maguire is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, her work has had a substantial impact on medical diagnostics and therapeutics.

Latest Patents

One of her latest patents involves an isolated peptide or polypeptide of the extracellular portion of the human interferon receptor (IFN-R). This patent describes a monoclonal antibody that targets the human interferon type I receptor, recognizing its extracellular domain and possessing neutralizing capabilities against the biological properties of human type I interferon. The diagnostic and therapeutic applications of this monoclonal antibody are also outlined in her patent. Another patent focuses on monoclonal antibodies against the interferon receptor, which also exhibit neutralizing properties.

Career Highlights

Throughout her career, Debborah has worked with notable companies such as Laboratoire Européen de Biotechnologie S.A. and Medisup International N.V. Her innovative work in these organizations has contributed to advancements in biotechnology and therapeutic solutions.

Collaborations

Debborah has collaborated with esteemed colleagues, including Patrick Benoit and Francois Meyer. These partnerships have fostered a collaborative environment that enhances research and development in her field.

Conclusion

Debborah Maguire's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor. Her work continues to influence the development of innovative medical solutions.